Published in Diabetes Care on October 07, 2013
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond) (2015) 1.14
Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? Indian J Endocrinol Metab (2016) 1.09
Diabetic Stroke Severity: Epigenetic Remodeling and Neuronal, Glial, and Vascular Dysfunction. Diabetes (2015) 0.86
Why do some patients with type 1 diabetes live so long? World J Diabetes (2014) 0.77
Ischemic Stroke and Its Risk Factors in a Registry-Based Large Cross-Sectional Diabetic Cohort in a Country Facing a Diabetes Epidemic. J Diabetes Res (2016) 0.77
2D-1H proton magnetic resonance spectroscopic imaging study on brain metabolite alterations in patients with diabetic hypertension. Mol Med Rep (2015) 0.76
The association between retinal vasculature changes and stroke: a literature review and Meta-analysis. Int J Ophthalmol (2017) 0.75
Event and Cost Offsets of Switching 20% of the Type 1 Diabetes Population in Germany From Multiple Daily Injections to Continuous Subcutaneous Insulin Infusion: A 4-Year Simulation Model. J Diabetes Sci Technol (2016) 0.75
Progress in Defining the Genetic Basis of Diabetic Complications. Curr Diab Rep (2017) 0.75
Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet (1991) 12.30
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol (2010) 5.76
Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension (2005) 4.08
Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) (1987) 2.88
Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. Arch Intern Med (1999) 2.75
Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol (2001) 2.51
Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts. Stroke (2005) 2.43
Elevated risk of stroke among patients with end-stage renal disease. Kidney Int (2003) 2.35
Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses' Health Study. Diabetes Care (2007) 2.33
Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia (1998) 2.25
The natural history of lacunar infarction: the Oxfordshire Community Stroke Project. Stroke (1987) 2.24
Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients. Diabet Med (2008) 1.91
Retinal microvascular abnormalities and risk of lacunar stroke: Atherosclerosis Risk in Communities Study. Stroke (2010) 1.91
Incidence of the major stroke subtypes: initial findings from the North East Melbourne stroke incidence study (NEMESIS). Stroke (2001) 1.69
Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia (2001) 1.56
Cerebral small vessel disease and chronic kidney disease (CKD): results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci (2008) 1.46
Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis. Stroke (2009) 1.43
Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int (1993) 1.42
Does microvascular disease predict macrovascular events in type 2 diabetes? Atherosclerosis (2011) 1.38
Is diabetic retinopathy an independent risk factor for ischemic stroke? Stroke (2006) 1.28
Upper gastrointestinal bleeding in patients with chronic renal failure. Ann Intern Med (1985) 1.21
Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus. Diabet Med (2007) 0.97
Diabetes mellitus and ischemic stroke in the young: clinical features and long-term prognosis. Neurology (2011) 0.94
Uremic bleeding: pathophysiology and clinical risk factors. Thromb Res (2005) 0.92
Rates and predictors of risk of stroke and its subtypes in diabetes: a prospective observational study. J Neurol Neurosurg Psychiatry (2012) 0.89
Type 1 diabetes as a risk factor for stroke in men and women aged 15-49: a nationwide study from Sweden. Diabet Med (2006) 0.87
Predictors of and survival after incident stroke in type 1 diabetes. Diab Vasc Dis Res (2012) 0.83
Eleven-year trends of stroke in Turku, Finland. Neuroepidemiology (2003) 0.80
Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke (2009) 3.39
Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav (2007) 3.19
Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA (2005) 3.01
Prognosis and safety of anticoagulation in intracranial artery dissections in adults. Stroke (2007) 2.95
Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology (2012) 2.91
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes (2009) 2.80
European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke (2014) 2.71
Safety of thrombolysis in stroke mimics: results from a multicenter cohort study. Stroke (2013) 2.44
Stroke mimics and intravenous thrombolysis. Ann Emerg Med (2011) 2.37
Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes. J Intern Med (2011) 2.30
Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care (2005) 2.26
Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care (2011) 2.20
The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care (2011) 2.16
Sex-related differences in the long-term risk of microvascular complications by age at onset of type 1 diabetes. Diabetologia (2011) 2.07
Leisure-time physical activity and development and progression of diabetic nephropathy in type 1 diabetes: the FinnDiane Study. Diabetologia (2015) 2.05
Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes. Diabetologia (2011) 1.90
Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol (2011) 1.82
Off-label thrombolysis is not associated with poor outcome in patients with stroke. Stroke (2010) 1.80
New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet (2012) 1.79
Mast cell stabilization reduces hemorrhage formation and mortality after administration of thrombolytics in experimental ischemic stroke. Circulation (2007) 1.73
Cyclodextrin protects podocytes in diabetic kidney disease. Diabetes (2013) 1.71
Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens (2006) 1.62
A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes (2009) 1.55
Reorganization of the primary somatosensory cortex during stroke recovery. Clin Neurophysiol (2010) 1.51
Lipid profiles and outcome in patients treated by intravenous thrombolysis for cerebral ischemia. Neurology (2012) 1.51
Birth weight is inversely correlated to adult systolic blood pressure and pulse pressure in type 1 diabetes. Hypertension (2004) 1.51
1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol (2008) 1.51
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol (2013) 1.49
Characteristics and outcomes of patients with multiple cervical artery dissection. Stroke (2013) 1.46
Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score. Ann Neurol (2012) 1.44
Is CT or MRI the method of choice for imaging patients with acute stroke? Why should men divide if fate has united? Stroke (2002) 1.43
Diffusion-weighted MR imaging in normal human brains in various age groups. AJNR Am J Neuroradiol (2002) 1.43
Statins after ischemic stroke of undetermined etiology in young adults. Neurology (2011) 1.42
Prevalence of stenoses and occlusions of brain-supplying arteries in young stroke patients. Neurology (2013) 1.42
Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes--indication of an increased environmental pressure? Diabetologia (2003) 1.41
Variation in SLC19A3 and Protection From Microvascular Damage in Type 1 Diabetes. Diabetes (2015) 1.40
Many patients with Type 1 diabetes estimate their prandial insulin need inappropriately. J Diabetes (2010) 1.39
Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy. Diabetes (2012) 1.36
High-throughput pedigree drawing. Eur J Hum Genet (2005) 1.36
Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care (2005) 1.35
Vascular endothelial growth factor receptor 3 directly regulates murine neurogenesis. Genes Dev (2011) 1.35
Long-term outcome after intravenous thrombolysis of basilar artery occlusion. JAMA (2004) 1.30
Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes (2003) 1.29
Serum concentration of cystatin C and risk of end-stage renal disease in diabetes. Diabetes Care (2012) 1.26
Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study. BMJ (2011) 1.26
SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke (2012) 1.26
Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients study. Stroke (2013) 1.25
Heritability of proliferative diabetic retinopathy. Diabetes (2008) 1.25
Antiplatelets versus anticoagulation in cervical artery dissection. Stroke (2007) 1.25
The MIF receptor CD74 in diabetic podocyte injury. J Am Soc Nephrol (2008) 1.22
Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe). Invest Ophthalmol Vis Sci (2011) 1.22
Cerebral mast cells regulate early ischemic brain swelling and neutrophil accumulation. J Cereb Blood Flow Metab (2006) 1.21
Demographic and geographic vascular risk factor differences in European young adults with ischemic stroke: the 15 cities young stroke study. Stroke (2012) 1.20
Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes. Diabetes (2008) 1.20
Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes. Diabetes Care (2009) 1.18
Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years. Diabetes Care (2003) 1.17
Stroke thrombolysis: save a minute, save a day. Stroke (2014) 1.17
Genetic and environmental effects on fasting and postchallenge plasma glucose and serum insulin values in Finnish twins. J Clin Endocrinol Metab (2005) 1.17
Incidence of type 1 diabetes in Finland. JAMA (2013) 1.15
Altered age-related blood pressure pattern in type 1 diabetes. Circulation (2004) 1.15
Lifestyle risk factors for ischemic stroke and transient ischemic attack in young adults in the Stroke in Young Fabry Patients study. Stroke (2012) 1.14
Advanced glycation end products are direct modulators of β-cell function. Diabetes (2011) 1.14
Cervical artery dissection: trauma and other potential mechanical trigger events. Neurology (2013) 1.12
Outcome by stroke etiology in patients receiving thrombolytic treatment: descriptive subtype analysis. Stroke (2010) 1.11
Health-related quality of life in patients with type 1 diabetes--association with diabetic complications (the FinnDiane Study). Nephrol Dial Transplant (2009) 1.10